Literature DB >> 22609311

Endothelial cell activation promotes foam cell formation by monocytes following transendothelial migration in an in vitro model.

Clare L V Westhorpe1, Eric M Dufour, Anna Maisa, Anthony Jaworowski, Suzanne M Crowe, William A Muller.   

Abstract

Foam cells are a pathological feature present at all stages of atherosclerosis. Foam cells develop from monocytes that enter the nascent atheroma and subsequently ingest modified low density lipoproteins (LDL). The regulation of this process has previously been studied in vitro using cultured macrophage fed modified LDL. We used our existing in vitro model of transendothelial migration (TEM) to study this process in a more physiologically relevant setting. In our model, monocytes undergo TEM across a primary endothelial monolayer into an underlying three-dimensional collagen matrix in the presence of 20% human serum. Foam cells were detected by Oil Red O staining for intracellular lipid droplets. We demonstrate that sub-endothelial monocytes can develop into foam cells within 48 h of TEM across TNF-α activated endothelium, in the absence of additional lipids. Our data indicate a role for both monocyte-endothelial interactions and soluble factors in the regulation of foam cell development, including oxidation of LDL in situ from lipid present in culture medium following TNF-α stimulation of the endothelial cells. Our study provides a simple model for investigating foam cell development in vitro that mimics cell migration in vivo, and demonstrates the critical role of inflammation in regulating early atherogenic events.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609311      PMCID: PMC3408785          DOI: 10.1016/j.yexmp.2012.03.014

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  32 in total

1.  Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo.

Authors:  G J Randolph; K Inaba; D F Robbiani; R M Steinman; W A Muller
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

2.  The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity.

Authors:  S W Sakr; R J Eddy; H Barth; F Wang; S Greenberg; F R Maxfield; I Tabas
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Authors:  Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

4.  The pivotal role of scavenger receptor CD36 and phagocyte-derived oxidants in oxidized low density lipoprotein-induced adhesion to endothelial cells.

Authors:  Steffi Kopprasch; Jens Pietzsch; Thomas Westendorf; Hans-Joachim Kruse; Jürgen Grässler
Journal:  Int J Biochem Cell Biol       Date:  2004-03       Impact factor: 5.085

Review 5.  Role of oxidative modifications in atherosclerosis.

Authors:  Roland Stocker; John F Keaney
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

6.  Oxidized low density lipoprotein-induced LFA-1-dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway.

Authors:  Shinichiro Mine; Takahiro Tabata; Youichiro Wada; Takeshi Fujisaki; Takeshi Iida; Noriko Noguchi; Etsuo Niki; Tatsuhiko Kodama; Yoshiya Tanaka
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

7.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages.

Authors:  T Schaffner; K Taylor; E J Bartucci; K Fischer-Dzoga; J H Beeson; S Glagov; R W Wissler
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

8.  Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; S E Dana; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

Review 9.  Macrophage cholesteryl ester mobilization and atherosclerosis.

Authors:  Shobha Ghosh; Bin Zhao; Jinghua Bie; Jingmei Song
Journal:  Vascul Pharmacol       Date:  2009-10-28       Impact factor: 5.773

10.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins.

Authors:  M S Brown; J L Goldstein; M Krieger; Y K Ho; R G Anderson
Journal:  J Cell Biol       Date:  1979-09       Impact factor: 10.539

View more
  13 in total

Review 1.  Inflammation-induced foam cell formation in chronic inflammatory disease.

Authors:  Thomas A Angelovich; Anna C Hearps; Anthony Jaworowski
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

2.  Novel ex vivo culture method for human monocytes uses shear flow to prevent total loss of transendothelial diapedesis function.

Authors:  Yoshiaki Tsubota; Jeremy M Frey; Elaine W Raines
Journal:  J Leukoc Biol       Date:  2013-09-04       Impact factor: 4.962

Review 3.  Secretory leukocyte protease inhibitor promising protective roles in obesity-associated atherosclerosis.

Authors:  Qiao-Qing Zhong; Xiang Wang; Yun-Feng Li; Li-Jun Peng; Zhi-Sheng Jiang
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

4.  Monocytes from HIV-infected individuals show impaired cholesterol efflux and increased foam cell formation after transendothelial migration.

Authors:  Anna Maisa; Anna C Hearps; Thomas A Angelovich; Candida F Pereira; Jingling Zhou; Margaret D Y Shi; Clovis S Palmer; William A Muller; Suzanne M Crowe; Anthony Jaworowski
Journal:  AIDS       Date:  2015-07-31       Impact factor: 4.177

5.  Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver.

Authors:  Henning W Zimmermann; Tony Bruns; Chris J Weston; Stuart M Curbishley; Evaggelia Liaskou; Ka-Kit Li; Yazid J Resheq; Paul W Badenhorst; David H Adams
Journal:  Hepatology       Date:  2015-11-23       Impact factor: 17.425

6.  MicroRNA-497 Induces Apoptosis and Suppresses Proliferation via the Bcl-2/Bax-Caspase9-Caspase3 Pathway and Cyclin D2 Protein in HUVECs.

Authors:  Ridong Wu; Shi Tang; Mian Wang; Xiangdong Xu; Chen Yao; Shenming Wang
Journal:  PLoS One       Date:  2016-12-05       Impact factor: 3.240

7.  Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV.

Authors:  Martha A Belury; Emily Bowman; Janelle Gabriel; Brandon Snyder; Manjusha Kulkarni; Marilly Palettas; Xiaokui Mo; Jordan E Lake; David Zidar; Scott F Sieg; Benigno Rodriguez; Martin P Playford; Adriana Andrade; Daniel R Kuritzkes; Nehal N Mehta; Michael M Lederman; Nicholas T Funderburg
Journal:  Pathog Immun       Date:  2017-10-06

8.  Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions.

Authors:  Thomas A Angelovich; Anna C Hearps; Anna Maisa; Theodoros Kelesidis; Anthony Jaworowski
Journal:  J Vis Exp       Date:  2017-10-17       Impact factor: 1.424

9.  Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism.

Authors:  Nadia M Krasner; Yasuo Ido; Neil B Ruderman; Jose M Cacicedo
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

10.  miR-26a inhibits atherosclerosis progression by targeting TRPC3.

Authors:  Min Feng; Daqian Xu; Lirui Wang
Journal:  Cell Biosci       Date:  2018-01-19       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.